Stocks-VXRT-Vaxart Inc

VXRT Vaxart Inc

1.08 -0.02 (-1.82%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest

Overview

Prev Close1.08
Day's Range 1.05 - 1.10
52 Week Range 0.7101 - 5.42
Average Volume (3M)3.28M
1-Year Return-77.85%
Beta0.4852
Market Cap141.75M
P/E Ratio
Revenue159K
EPS-0.8288
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Andrei Floroiu, MBA
Employees 125

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Vaxart Inc's revenues decreased by 77.95% and amounted to 892.00K. Net income decreased by 118.72% to -70.47M. Net assets increased by 51.97% to 187.53M and EPS decreased from -0.36 to -0.58.
VXRT's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-2,329.65%
Operating Margin
-65,823.27%
Return On Investment
-47.16%
12/21
03/22
06/22
09/22
Total Revenue
74K
85K
0
0
Gross Profit
N/A
N/A
0
-827K
Operating Income
-21.21M
-24.78M
-29.25M
-29.43M
Net Income
-20.76M
-25.1M
-29.43M
-29.31M